Ignite Creation Date:
2025-12-25 @ 2:44 AM
Ignite Modification Date:
2025-12-26 @ 1:24 AM
Study NCT ID:
NCT06092333
Status:
RECRUITING
Last Update Posted:
2025-12-08
First Post:
2023-10-19
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B
Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-01-31
Start Date Type:
ACTUAL
Primary Completion Date:
2028-02-29
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-08-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-10-19
First Submit QC Date:
None
Study First Post Date:
2023-10-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-05
Last Update Post Date:
2025-12-08
Last Update Post Date Type:
ESTIMATED